MEDsan SARS-CoV-2 Antigen Rapid Test
The MEDsan SARS-Cov-2 Antigen Rapid Test is a lateral flow test used for the detection of SARS-CoV-2 antigens.
This test is a lateral flow immuno-chromatographic assay intended for the in vitro qualitative detection of SARS-CoV-2 antigens and can detect those infected even in asymptomatic cases.
With 92.5%* clinical sensitivity the MEDsan SARS-Cov-2 Antigen Rapid tests are CE Certified and identifies those infected with the Virus by testing for antigens. These tests are not effected by the known mutations of SARS-CoV-2.
Listed by the BfArM Federal Institute for Drugs and Medical Devices
Officially validated by Paul-Ehrlich-Institute (Federal Institute for Vaccines and Biomedicines)
This product meets EU standards for health, safety, and environmental protection.
This Test is Single use only.
**IF YOU ARE DISPLAYING ANY SYMPTOMS FOR COVID-19 PLEASE CALL 111. THIS TEST IS NOT INTENDED AS AN ALTERNATIVE TO THE GOVERNMENT PCR TESTING**
Regardless of Test results you MUST continue to follow all Government COVID-19 restrictions, regulations and guidelines.
Out of stock
The MEDsan SARS-CoV-2 Antigen Rapid tests are :
- Clinical Sensitivity: 92.5%*
- Clinical Specificity: 99.8%*
- Detects even low levels of the virus
- Generates results in just 15-20 minutes
- No additional equipment required
- Available to buy as a single test kit
- More cost effective than PCR testing
- CE Certified
- MEDsan SARS-CoV-2 Antigen Rapid Test is officially validated by Paul-Ehrlich-Institute (Federal Institute of Vaccines and Biomedicines)
MEDsan rapid antigen tests is a lateral flow immunochromatographic assay intended for the in vitro qualitative detection of SARS-CoV-2 antigens in human nasopharyngeal or oropharyngeal secretions.
The test uses SARS-CoV-2 antibodies ( test lineT ) and goat anti-mouse IgG (control line C ) immobilised on a nitrocellulose strip.
The results of this test are not affected by the known mutations of SARS-CoV-2.
The Test Kit will detect the presence of antigens of SARS-CoV-2 in those infected with the disease between approximately 1-14 days of being infected. The tests are easy to use, can screen anywhere, identifies infection even in those mild or asymptomatic cases and is registered in the European Union.
The MEDsan SARS-CoV-2 Antigen Rapid tests are currently being used across Europe in UK Care Homes, UK World Superbike teams, GP Practices in Netherlands, Bundesliga Football Teams and more.
Should the test gain a positive response you must contact the COVID 111 Hotline (call 111 on landline or mobile phone) and self isolate.
As with all diagnostic tests, a definitive clinical diagnosis should not be based on the result of a single test but should only be made by medical professional bodies after all clinical and laboratory findings have been evaluated.
*Please note: like all COVID-19 tests, accuracy is not 100% and can therefore result in both false negative and false positive result. This test does not negate the need to take all precautions surrounding the protection for yourself and others in contracting, and the transmission of, COVID-19.
MEDsan's Rapid Coronavirus Tests are manufactured in Germany by MEDsan GmbH, an independent company based in Hamberg with 44 years of experience developing and manufacturing immunobiological and isopathic pharmaceuticals and medical devices.
|Dimensions||6 × 4 × 1 cm|
Test Device, Swab, Buffer, Extraction Tube, Component, Instructions for Use